Citalopram was officially issued

In December 2006, Jiangsu Jihua Lingda Pharmaceutical Co., Ltd. (Jiangsu Lingda) formally submitted the DMF document of the company's first export product, citalopram hydrobromide, to the Drug Examination Center (CDER) of the U.S. Food and Drug Administration (FDA). It was in favor of obtaining the DMF registration number in January 2007, marking that the group's products had made substantial progress in entering the European and American markets and meeting FDA certification and inspection.